Exousia Bio (LMMY) Receivables - Other (2024)

Exousia Bio (LMMY) posted Receivables - Other of $1439.0 for Q4 2024, up 65.97% sequentially from $867.0 in Q3 2024.

Analysis

Exousia Bio (LMMY) Receivables - Other (2024) Analysis & Trends

Exousia Bio (LMMY) has 1 years of Receivables - Other data on file, last reported at $1439.0 in Q4 2024.

Quarterly Receivables - Other changed N/A year-over-year to $1439.0 in Q4 2024, while the trailing twelve-month figure through Nov 2024 was $1439.0 (changed N/A YoY) and the FY2024 annual result came in at $436.0, changed N/A from the prior year.
Receivables - Other grew to $1439.0 in Q4 2024 per LMMY's latest filing, from $867.0 in the prior quarter.
The five-year high for Receivables - Other was $1439.0 in Q4 2024, with the low at $436.0 in Q2 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	New Oriental Education & Technology	94.81 Bn	92.07 Bn	812.22 Mn
2	Laureate Education	5.12 Bn	4.96 Bn	237.67 Mn
3	Graham Holdings	4.84 Bn	3.59 Bn	777.03 Mn
4	Covista	4.55 Bn	4.14 Bn	284.63 Mn
5	Grand Canyon Education	3.99 Bn	3.72 Bn	204.08 Mn
6	Stride	3.71 Bn	2.75 Bn	217.28 Mn
7	McGraw Hill	2.54 Bn	2.34 Bn	439.20 Mn
8	Perdoceo Education	2.10 Bn	797.06 Mn	162.46 Mn
9	TAL Education	1.94 Bn	-740.46 Mn	227.32 Mn
10	Exousia Bio	368,824.87	368,824.87	-62,108.00

Historic Data

Download Data